Tag Archives: pancreatic cancer

Early Oncology Partnering Forum

Posted on 15 February 2011 by Evan Richardson

From 21-22 February 2011, Cato Research will be attending the Early Oncology Partnering Forum held in San Francisco, CA.  This conference facilitates and encourages discussion and collaborations between companies that are developing innovative products with more established companies as partners. … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , , , , , | Comments Off

35th European Society for Medical Oncology Congress

Posted on 23 September 2010 by Ask-Cato.com Contributor

Image via Wikipedia The annual European Society for Medical Oncology (ESMO) meeting brings together medical oncologists from both Europe and all parts of the world.  As per ESMO’s 2010 meeting President, Dr. David Kerr, announcement: The ESMO Congress is a … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , , | 1 Comment

Cato at the Cancer Vaccines Meeting

Posted on 29 June 2010 by Evan Richardson

This week, Cato Research is attending the Cancer Vaccines meeting in Cambridge, MA on 29 and 30 June.  The conference is the first meeting dedicated to progressing cancer vaccines to market and will feature 21 of the world’s leading experts … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , | Comments Off

Approval of Therapeutic Cancer Vaccines

Posted on 12 May 2010 by Ask-Cato.com Contributor

Last month, Dendreon was granted approval for Provenge®, the first cell based cancer vaccine for treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.  Provenge is the first cancer treatment that utilizes the strength of the … Continue reading →

Posted in FDA, Industry News, Publications | Tagged , , , , , , , , , , , , , , , , , , , | 1 Comment